Literature DB >> 11486899

A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping.

M Skrygan1, B Bartholomé, L Bonafé, N Blau, K Bartholomé.   

Abstract

Four different mutations in the GTP cyclohydrolase I gene were found (P199L, M211V, IVS5+1G>A, G203R) in 6 out of 33 families with dopa-responsive dystonia. A splice mutation (IVS5+1G>A) located at the border of exon 5 to intron 5 was found in one of these families. Three members of the family carry the IVS5+1G>A mutation on one allele, inherited from the father to the daughter and son. Examination of the mRNA showed an exon 5 skipping that results in a reduction of enzyme activity in cultured fibroblasts to 4-17% compared to controls. The father and daughter never had clinical symptoms of dopa-responsive dystonia. The son was symptomatic at the age of 3 years and was treated successfully with L-dopa/carbidopa. After 20 years this therapy was terminated and for the next 6 years he was free of symptoms. With increased motoric activity, symptoms reappeared and the therapy was reintroduced.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486899     DOI: 10.1023/a:1010544316387

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?

Authors:  J Tassin; A Dürr; A M Bonnet; R Gil; M Vidailhet; C B Lücking; J Y Goas; F Durif; M Abada; B Echenne; J Motte; A Lagueny; L Lacomblez; P Jedynak; B Bartholomé; Y Agid; A Brice
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

3.  Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts.

Authors:  L Bonafé; B Thöny; W Leimbacher; L Kierat; N Blau
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

4.  Co-factor insufficiency in dystonia-parkinsonian syndrome.

Authors:  L J Ozelius; X O Breakefield
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Biochemical hallmarks of tyrosine hydroxylase deficiency.

Authors:  C Bräutigam; R A Wevers; R J Jansen; J A Smeitink; J F de Rijk-van Andel; F J Gabreëls; G F Hoffmann
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

Review 6.  Tetrahydrobiopterin biosynthesis, regeneration and functions.

Authors:  B Thöny; G Auerbach; N Blau
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

7.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Dopa-responsive dystonia: long-term treatment response and prognosis.

Authors:  T G Nygaard; C D Marsden; S Fahn
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

9.  Dopa-responsive dystonia: a clinical and molecular genetic study.

Authors:  O Bandmann; E M Valente; P Holmans; R A Surtees; J H Walters; R A Wevers; C D Marsden; N W Wood
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

10.  Biochemical and neurophysiological investigations in two forms of Segawa's disease.

Authors:  W Görke; K Bartholomé
Journal:  Neuropediatrics       Date:  1990-02       Impact factor: 1.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.